Awardee OrganizationWEILL MEDICAL COLL OF CORNELL UNIV
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Transcription regulation underlies the diversity of cell types and functions. The process of transcription itself
has multiple steps that may be regulated separately. Promoter-proximal RNA Pol II pausing has recently been
described as a widespread rate-limiting step of transcription and a possible point of gene regulation. Studies
disrupting the critical pausing factor Negative elongation factor-B (Nelf-b) in mouse and mouse embryonic stem
cells (mES) highlighted its essential role in development and a cross-talk with FGF/ERK signaling transduction.
However, it is unclear what role pausing plays in mammalian development. Furthermore, it is unclear how
pausing may affect specific targets of FGF/ERK signaling, and whether this cross-talk is relevant in vivo.
The long-term goal of this proposal is to establish a molecular understanding of how gene regulation can be
achieved at the level of promoter-proximal pausing during transcription. The objective of the present proposal is
to mechanistically determine the role of pausing during epiblast pluripotency transitions in early mammalian
development. This objective will be achieved by a detailed phenotypic and transcriptomic analysis of Nelf-b-/-
embryos at several early developmental stages to analyze pluripotency transitions (Aim 1). To expand on these
results and interrogate pausing at a high molecular and temporal resolution, a Nelf-b-degron mES cell line has
been established to test the immediate and direct effects of pausing-loss in mES cells under different signaling
conditions. I will utilize nascent RNA-seq techniques and directed differentiation approaches to build a
mechanistic link between pausing, FGF/ERK transcriptional activation, and pluripotency transitions in embryos
and mES cells (Aim 2). My central hypothesis is that pausing is required for epiblast pluripotency
transitions in mouse development via direct regulation of FGF/ERK transcriptional targets.
The expected outcome of this project is to uncover the mechanistic link between pausing and signal
transduction, explain the role of pausing in mammalian development. It promises to yield novel insights into gene
regulation at the pausing level. The link between pausing and signaling is of high importance to other biological
contexts considering the prevalence of pausing and necessity of signal transduction to perform fundamental
cellular functions beyond responses to FGF/ERK in development. Furthermore, given that FGF/ERK signaling
is amongst the top dysregulated pathways in developmental diseases and malignancies, insights into the
molecular mechanisms of this pathway will yield novel insights to therapeutically target it.
Public Health Relevance Statement
PROJECT NARRATIVE
Regulation of transcription dictates cells’ fates, functions, and potential in development and disease. Promoter-
proximal RNA Polymerase II Pausing has been shown to be a critical rate-limiting step of transcription that can
control transcription’s outcome and response to extracellular signals in certain scenarios. This study aims to
understand the mechanisms of Pausing influence on gene regulation and signal response in early mammalian
development in vivo and in vitro, which will give insights into how this process may affect cellular response to
extracellular signals and open the door to manipulating this process for therapeutic purposes.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
853
DUNS Number
060217502
UEI
YNT8TCJH8FQ8
Project Start Date
01-April-2021
Project End Date
31-March-2025
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$53,974
Direct Costs
$53,974
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$53,974
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F30HD103398-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F30HD103398-04
Patents
No Patents information available for 5F30HD103398-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F30HD103398-04
Clinical Studies
No Clinical Studies information available for 5F30HD103398-04
News and More
Related News Releases
No news release information available for 5F30HD103398-04
History
No Historical information available for 5F30HD103398-04
Similar Projects
No Similar Projects information available for 5F30HD103398-04